Blue Bell Private Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Blue Bell Private Wealth Management’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-19	Closed	-$624	–	747
2025 Q2	$624	Hold	19	–	–	﹤0.01%	697
2025 Q1	$588	Hold	19	–	–	﹤0.01%	694
2024 Q4	$719	Hold	19	–	–	﹤0.01%	648
2024 Q3	$833	Hold	19	–	–	﹤0.01%	652
2024 Q2	$773	Hold	19	–	–	﹤0.01%	677
2024 Q1	$842	Hold	19	–	–	﹤0.01%	687
2023 Q4	$855	Hold	19	–	–	﹤0.01%	681
2023 Q3	$753	Hold	19	–	–	﹤0.01%	642
2023 Q2	$897	Hold	19	–	–	﹤0.01%	643
2023 Q1	$912	Hold	19	–	–	﹤0.01%	621
2022 Q4	$936	Sell	19 -22	-54%	-$1.13K	﹤0.01%	640
2022 Q3	$2K	Hold	41	–	–	﹤0.01%	597
2022 Q2	$2K	Sell	41 -85	-67%	-$4.31K	﹤0.01%	637
2022 Q1	$8K	Hold	126	–	–	﹤0.01%	462
2021 Q4	$10K	Buy	+126	New	+$10.6K	﹤0.01%	401

Other funds holding GNOM

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Insight Advisors Newtown, Pennsylvania $567M AUM 25.52% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

Blue Bell Private Wealth Management's GNOM Position: Q3 2025 in Review

Blue Bell Private Wealth Management sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q3 2025, closing a stake of 19 shares — an estimated $624 sold.

Blue Bell Private Wealth Management first reported a position in GNOM in Q4 2021 and held it in 15 quarters. The position peaked at $10K in Q4 2021. 43 funds tracked by Wall St. Rank hold GNOM as of Q3 2025.

Blue Bell Private Wealth Management reported no remaining Global X Genomics & Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
Blue Bell Private Wealth Management sold 19 Global X Genomics & Biotechnology ETF shares in Q3 2025, an estimated $624.
Blue Bell Private Wealth Management first reported a position in Global X Genomics & Biotechnology ETF in Q4 2021 and held it in 15 quarters.
Blue Bell Private Wealth Management's Global X Genomics & Biotechnology ETF position peaked at $10K in Q4 2021.
43 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2025.

Based on Blue Bell Private Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.